Join us as we explore the use of multiple databases in drug safety studies.

Register today to listen to a recorded presentation of our newest i3 Drug Safety web conference where we’ll discuss how conducting large-scale multiple database safety studies can be used to address the challenges of safety signal identification and regulatory requirements for the post-marketing surveillance of your new drug product.

In particular we’ll share two examples involving the design and implementation of multiple database studies for drug safety, and how they provided greater statistical power and a stronger foundation for drawing inferences from observational (non-interventional) work through reproducibility and improved generalizability.

www.i3drugsafety.com